Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06695416 · ClinicalTrials.gov registry record

Community-based Partnership's Efficacy in Decreasing Injury Rates At Night in Dallas, TX

A clinical trial of Blood Alcohol Concentration and Drunk Driving, sponsored by Methodist Health System.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT06695416 is a study of Blood Alcohol Concentration and Drunk Driving that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06695416, a study of Blood Alcohol Concentration and Drunk Driving, is actively recruiting participants, sponsored by Methodist Health System.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

According to the Centers for Disease Control and Prevention (CDC), "88,000 people die every year due to alcohol-related issues including homicide, sexual assault, intimate partner violence, and suicide". In the city of Dallas, violent crimes have decreased by roughly 4% in 2022 compared to 2021. Dallas Police Department (DPD) implemented changes in May 2021 to combat violent crimes.

Study Locations (1)

Texas

  • Methodist Dallas Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2023-04-28
Est. Completion 2025-04-28

Sponsor

Methodist Health System

125 total trials

What the Registry Record Tells You About NCT06695416

The ClinicalTrials.gov registry entry for NCT06695416 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Blood Alcohol Concentration appearing as the primary indexed condition, and to 0 interventions.

NCT06695416 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06695416 about?

NCT06695416 is a clinical study titled "Community-based Partnership's Efficacy in Decreasing Injury Rates At Night in Dallas, TX". According to the Centers for Disease Control and Prevention (CDC), "88,000 people die every year due to alcohol-related issues including homicide, sexual assault, intimate partner violence, and suicide". In the city of Dallas, violent crimes have decreased by roughly 4% in 2022 compared to 2021. Dal...

What is the current status of trial NCT06695416?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2023-04-28. Estimated completion is 2025-04-28.

What conditions does trial NCT06695416 study?

This clinical trial studies the following conditions: Blood Alcohol Concentration, Drunk Driving.

Who is sponsoring clinical trial NCT06695416?

This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06695416 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.